drug discovery

News

GSK turns to AI specialist Tempus for R&D productivity boost

One of the first actions by GSK's recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma's R&D productivi

News

Illumina_collaboration_with_AstraZeneca_image

AstraZeneca builds its AI capabilities again with Illumina t...

AstraZeneca has teamed up with DNA sequencing giant Illumina on a new programme that will use artificial intelligence to find new targets for drug discovery by sifting through vast arrays o

News

Cells and biological chain,molecules and abstract conception,3d rendering. Computer digital drawing.

AZ/BenevolentAI collab achieves AI-enabled further milestone...

Two additional novel AI-generated targets for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF) have been discovered using the Benevolent Platform and selected for AstraZ

Digital

AI tissue analysis enables rapid discovery of drug candidate...

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient gr

News

Despite ban, Martin Shkreli can't seem to kick the pharma ha...

Given that Martin Shkreli has a lifetime restraining order preventing him from working in the pharma industry, it will raise a few eyebrows that his new company – launched just two months a

News